Researchers at King Faisal Specialist Hospital and Research Centre in Saudi Arabia have made significant strides in making advanced medical treatments more accessible and cost-effective. Since 2020, the hospital has successfully treated over 200 patients with CAR-T cell therapy, a type of cancer treatment that has traditionally been expensive and time-consuming. By moving production in-house, they have reduced the cost from approximately 1.3 million Saudi riyals to around 250,000, and cut the production time from 28 days to less than 14 days. This shift not only makes treatment more affordable but also faster, which is crucial for patients needing timely care.

This development is particularly important for people seeking innovative cancer treatments. With the cost of CAR-T therapy significantly lowered, more patients could potentially access this life-saving option. Additionally, the hospital has doubled its genomic testing capacity, indicating a broader integration of advanced diagnostics in treatment planning. The use of robotic-assisted surgeries has also increased, leading to shorter hospital stays, which can enhance recovery and reduce healthcare costs for patients.

The findings from King Faisal’s experience are based on practical applications rather than early-stage research. Their model emphasizes measurable indicators such as treatment volume, response time, and cost efficiency, rather than isolated successes. While the hospital’s approach has shown promising results, there is still uncertainty about whether this model can be replicated in other healthcare systems. However, their achievements highlight a potential pathway for integrating advanced therapies into routine clinical practice.

Source: globenewswire.com